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This study analyzes the effect of temperature, perfusate 
composition, pH, and variable manufacturing lots in pro-
longing kidney allograft survival with Concanavalin A (Con 
A). Cold temperature (4°C), crystalloid composition of the 
perfusates, and neutral or mildly alkaline pH were impor-
tant factors in the effect of Con A on prolonging allograft 
survival. Also, different lots of Con A from the same man-
ufacturer produced variable results in prolonging survival. 
Thus, multiple factors should be considered if Con A is to be 
used to prolong kidney allograft survival. 
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r ROLONGED allograft survival has been achieved mainly 
by suppression of the recipient's immune response. Few 
studies have been concerned with prolonging graft survival 
by inducing modification of the antigenicity or immu-
nogenicity of allografts. Treatment of allografts in vitro with 
c o r t i c o i d s , ' t h a l i d o m i d e , ^ urethane," radiation,^ or 
electrophoresis^'^ have prolonged the survival of some 
allografts to a greater degree than systemic administrationof 
these same agents. In vitro treatment of grafts with strep-
tokinase-streptodornase," ribonucleic acid,'or with purified 
recipient transplantation antigens'" does not prolong sur-
vival as well as pharmacological manipulations. Minimal or 
no immune reaction has been observed toward allografts 
treated in vitro with formalin, cyanide'^ or by freeze dry-
ing.'" Even these efforts to alter allograft immunogenicity 
have used test systems involving normal, unmodified recip-
ients. Such experimental systems are probably capable of 
detecting only the most profound alterations in graft immu-
nogenicity, some of which may even lead to loss of graft 
viability'^-'" 
We have developed a standard system for minimal immu-
nosuppression in dogs which itself is insufficient to prolong 
renal allografts. But, in the modified recipient, prolongation 
of graft survival by in vitro manipulation can readily be 
observed. For example, modification of renal allograft by 
perfusion in vitro w i th heterologous ant i lymphocyte 
globulin, dipyridamole, phytohemagglutinin, or with Con-
canavalin A (Con A) wil l significantly prolong graft function 
and life in minimally immunosuppressed dogs,""" 
Our best results have been obtained when dog kidney 
allografts were perfused in vitro at 4°C with 25 mg/L of Con 
A before transplantation. While ultimate rejection always 
occurred, dog allografts occasionally survived for as long as 
60 days. The doses of azathioprine used were not sufficient 
to produce prolonged survival of the kidney graft by itself. 
Similarly, perfusion of kidneys with optimal concentration 
of Con A had no effect on dogs who did not receive some 
systemic immunosuppression." 
In our initial experiments, perfusion of canine kidneys with 
Con A did not prolong the survival of transplanted dogs ifthe 
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perfusion in vitro was performed at25°C ratherthan at4°C.''' 
We hypothesized that Con A became clustered on the fluid 
membrane ofthe graft endothelium at the warmer tempera-
ture ""^' so that antigen masking was incomplete. In con-
trast, at4°Cthe fluid cell membrane may have been in a gel-
like state,''"^'^ which would al low the Con A to become more 
evenly diffused over the entire suface, thereby masking the 
evenly dispersed histocompatibility antigens. We further 
hypothesized that by placing the graft suddenly into the 
blood stream at 37°C immediately after transplantation, the 
proteins of blood became bound to the excess evenly 
distributed Con A on the endothelial membrane so that the 
antigen-masking effect was augmented." The present stud-
ies are an unsuccessful attemptto verify these hypotheses by 
experimental testing. 
Our work also investigates other important factors in pro-
longing kidney allograft survival wfth Con A, such as pH of 
the solution and the manufacturing lot of Con A used. This 
last factor is of considerable importance, particularly in 
view of recent findings on the rat m o d e l , w h i c h were not 
able to reproduce earlier results in prolonging kidney al-
lograft survival with Con A . " 
Material and Methods 
Experiment 1 
Forty-two adult mongrel dogs of either sex were randomly 
divided into seven groups of six dogs each. The dogs were 
nephrectomized and given heterotopically unrelated kid-
neys by standard operative techniques.'^'" After transplan-
tation, 20 mg of furosemide were given intravenously, and 
all recipient dogs were given azathioprine 5.0 mg/kg/day 
intravenously for three days, then 2.5 mg/kg/day orally 
until death. Serum creatinine was recorded daily The onset 
of rejection was defined as the day on which the creatinine 
was elevated above 2.0 mg%. 
Immediately after donor nephrectomy, the kidneys were 
flushed from a height of four feet (120 cm/water pressure) 
with 500 ml of Ringer's lactate solution (pH 6.5, 4°C, 
procaine 0.1 gm/L, heparin 10,000 U/L). The kidneys of 
Group I were controlled without Con A in the perfusate, 
while those in Group II were flushed wfth Ringer's and Con 
A* (25 g/ ml). The kidneys in Group III were flushed at 4°C 
with 500 ml of regular canine, normal pooled plasma 
containing 25 mg/L of Con A but neither procaine nor 
heparin. The kidneys from Groups IV to Vll were first 
perfused with Ringer's lactate (500 ml) and Con A (25 
mg/ L), and then a second time with 50 ml of either plasma at 
4°C (Group IV), Ringer's lactate at 4°C (Group V), Ringer's 
lactate at 37°C (Group VI), or plasma at 37°C (Group Vll), 
* Lot 210073, Cal Biochem Labs, San Diego, CA 
Excluded from analysis were five dogs that died in the first 
three days after transplantation from distemper, postopera-
tive hemorrhage, or anesthetic complications. 
Experiment 2 
Twenty-two mongrel dogs were divided into four groups: 
Group Vlll (n=5) without Con A in the perfusate, and 
Groups IX {n = 5), X (n = 6), and XI (n = 6) with 25 mg/L of 
Con A (Lot 210073 Cal Biochem Labs, San Diego, CA) inthe 
perfusate, maintained at pH 5.6, 6.5, and 7.6, respectively. 
The pH was raised from 6.5 to 7.6 in the Ringer's solution 
with NaHC03 0.1 N, and HCI 0.1 N was used to obtain a pH 
of 5.6. 
Experiment 3 
One more set of twenty mongrel dogs was divided into four 
groups of five dogs each: Group Xll as the control without 
Con A inthe perfusate; Group Xlll transplanted with kidneys 
flushed with Con A, 25 mg/L (Lot 330307-NaCI, Cal 
Biochem Labs); Group XIV with the same concentration of 
Con A but a different lot (Lot 610049-NaCl, Cal Biochem 
Labs), and Group XV using kidneys flushed with purified 
Con A (Lot 610049-NaCl, Fraction 11*). 
Results 
The survival of the recipients of all renal allografts is 
summarized in Figures 1-5. Dogs given normal kidneys 
rejected them in two weeks despite being immunosup-
pressed with azathioprine. Dogs transplanted with kidneys 
perfused with Con A in Ringer's lactate at 4°C survived for 
prolonged periods, while those which received Con A in 
plasma at 4°C did not (Figure 1), 
In Groups IV-VII the kidneys treated at 4°C with Con A were 
immediately reperfused with 50 ml of plasma or Ringer's 
lactate. The prolonged survival of kidneys perfused at 4°C 
with Con A was negated by plasma perfused at 4°C or 37°C 
(Figure 2). Similar negation of prolonged survival of the 
altered kidneys occurred when 50 ml of Ringer's solution at 
37°C were passed through the Con A-treated kidney (Figure 
3). 
Figure 4 shows the effect of pH on prolonging the survival of 
kidneys pretreated with Con A. The best results were 
obtained at pH 7.6. Figure 5 shows the effect of various lots 
of Con A in prolonging graft survival. While the original lots 
330307 and 610049 had no significant effect on prolonging 
kidney survival, the purified Con A (Fraction II) did signifi-
cantly affect the prolongation of kidney survival. 
* Fraction II supplied by Cal Biochem Labs (Dr. M.E. Shantz), It was 
obtained by passing Con A through a Sephadex-G 50 column and 
dialyzing it several times against glucose and NaCl. 
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Fig. 1 
Cumulative survival of canine kidney allografts perfused in vitro wi th 
Concanavalin A (Con A) in Ringer's lactate or regular dog plasma. These 
data include Groups I, I I , and I I I . 
-Con A 25 mg/L-pH 5.6 
Con A 25 mg/L-pH 6.5 
Con A 25 mg/L-pH 7.f 
20 25 30 35 
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Fig. 4 
Cumulative survival of canine kidney allografts perfused in vitro wi th 
Concanavalin A (Con A) in Ringer's lactate (4°C) at different pH levels. 
These data include Groups V l l l , IX, X, XI . 
> 60 
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^ ^ C o n A 25 mg/L (Lot 330307-NaCI) 
Con A 25 mg/L (Lot 610049-NaCl ) 
Con A 25 mg/L (Lot 610049-
Fractlon I ) 
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Fig. 2 
Cumulative survival of canine kidney allografts perfused in vitro wi th 
Concanavalin A (Con A) in Ringer's lactate and reperfused wi th regular 
dog plasma at 4°C or 37°C. These data include Groups I, I I , IV, and V l l . 
Fig. 5 
Cumulative survival of canine kidney allografts perfused in vitro wi th 
Concanavalin A (Con A) in Ringer's lactate at 4°C. The effect of various 
lots of Con A was tested. These data include Groups X l l , X l l l , XIV, XV. 
a 40 
-Con A 25 mg/L (Ringer's) 
+ Ringer's 37 "C 
Con A 25 mg/L ( Ringer's) 
+ Ringer's 4''C 
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Fig. 3 
Cumulative survival of canine kidney allografts perfused in vitro wi th 
Concanavalin A (Con A) in Ringer's lactate and reperfused wi th Ringer's at 
4°C or 37°C. These data include Groups I, I I , V, and V i . 
Discussion 
These experiments confirm our previous findings that ca-
nine renal allograft survival can be prolonged in minimally 
immunosuppressed recipients ifthe kidney is perfused with 
Con A in Ringer's lactate at 4°C." On the other hand, 
perfusion of kidneys with Con A in plasma at 4°C did not 
prolong the survival of dog kidney allografts. Plasma perfu-
sion of the kidney even after modification with Con A in 
Ringer's solution at 4°C totally negated the prolongation. Itis 
likely that the glycoproteins in plasma remove the Con A 
from its exposed position on the endothelium ofthe grafted 
kidney. In fact, perfusion with Ringer's solution at 37°C and 
to a lesser degree at 4°C reduces the graft modification 
initially obtained by perfusion with Con A at 4°C. These 
results shed some light on the mechanism by which Con A 
modifies the immunogenicity of renal allografts. Modifica-
t ion is obviously temperature dependent and can be 
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achieved only in the cold, although the exact optimal 
temperature is still unknown. The Con A is only loosely 
bound and can be effectively removed by plasma, presuma-
bly because of the high concentration of competitive Con A-
binding glycoproteins in plasma. It can even be partially 
removed by small volumes of Ringer's perfusate at 4°C, 
although ft is much more easily removed at the warmer 
temperature. It was previously considered that Con A, which 
is itself an immunosuppressive agent, acts synergistically 
with azathioprine to systemically immunosuppress the re-
cipient dogs. We found, however, that systemic administra-
tion of Con A with azathioprine could not prolong the 
survival of unmodified kidney allografts." 
Nevertheless, a serious question remains. How is it possible 
for Con A to effectively modify graft immunogenicity at the 
same temperatures in vivo that remove it most easily in 
vftro? One possibility is that Con A on graft endothelium 
activates immunologica l ly competent cells that f low 
through the graft in the first few minutes after grafting. Since 
it is known^" that Con A can transform T-cells non-
specifically, it is possible that it retains this mitogenic 
potential when it binds to cell membranes. Moreover, the 
known capacity of Con A to stimulate suppressive T-cells 
may in some way be augmented by attachment to the cell 
membrane.'^ 
Our studies also indicate that Con A in a neutral or slightly 
alkaline Ringer's solution had amore pronounced effect on 
determining prolongation of kidney allograft survival than in 
an acid Ringer's solution. Flushing the kidney with Con A at 
a lower pH (5.6) did not prolong survival as well as in the 
previous groups. So and Goldstein^'^ have already demon-
strated that the binding of Con A to methyl-a-D-man-
nopyranoside is pH dependent and was maximal at pH 6.2. 
Our in vivo studies indirectly confirmed their observations 
that very low or high pH reduced the maximal binding 
properties of Con A. 
Finally, our experiments show that ft is important to control 
the manufacturing lot of Con A used in order to achieve 
consistent results in modifyinggraft immunogenicity. Recent 
lots of Con A (1976-77) have produced more variable results 
than were obtained with the original lots used when these 
experiments began in 1973. Our recent experience indi-
cates that unless Con A isfurther purified (Fraction II), it does 
not prolong graft survival. These results may explain the 
difficulties that other investigators encountered in demon-
strating prolonged survival in the rat model.^^'" Further 
studies in our laboratories are investigating the effect of 
endotoxin on the Con A samples as the possible reason for 
the lack of consistency obtained by other researchers.^^'^^ 
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